Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jintiange Capsules for knee osteoarthritis
ChiCTR2400081839Phase 4Not yet recruiting
- Sponsor
- Shenzhen Traditional Chinese Medicine Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of jintiange in knee osteoarthritis (OA) (2 arms), sponsored by Shenzhen Traditional Chinese Medicine Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index pain score. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
jintiange
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400081839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081839.